April 2017 Respiratory Health

The FDA has approved Yosprala (aspirin and omeprazole, Aralez Pharmaceuticals) delayed-release tablets for patients requiring aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin-associated gastric ulcers.

Pet Peeves (April 2017)

By

This month's list includes patients with cigarette breath and fast talkers.